Review
. 2006 Jun;117(7 Suppl):152S-157S; discussion 158S-159S.
doi: 10.1097/01.prs.0000222534.79915.d3.
The efficacy of Apligraf in the treatment of diabetic foot ulcers
Affiliations
- PMID: 16799383
- DOI: 10.1097/01.prs.0000222534.79915.d3
Item in Clipboard
Review
The efficacy of Apligraf in the treatment of diabetic foot ulcers
Plast Reconstr Surg.
2006 Jun.
Abstract
Diabetic foot ulcerations can be a devastating complication of diabetes, causing prolonged hospitalization and significant morbidity. Previously identified risk factors include peripheral neuropathy, foot deformities, and poor wound healing due to an altered wound environment. Despite appropriate treatment, many diabetic ulcers fail to heal. Bioengineered tissue, such as Apligraf (Graftskin; Organogenesis Inc., Canton, Mass.), has been effectively and safely used to increase the incidence of complete wound closure and decrease the healing time. Studies have demonstrated that Apligraf works through the delivery of growth factors and cytokines to the chronic wound environment.
Similar articles
-
Special segment: soft tissue matrices--Apligraf bilayered skin substitute to augment healing of chronic wounds in diabetic patients.Foot Ankle Spec. 2009 Dec;2(6):299-302. doi: 10.1177/1938640009354041. Epub 2009 Nov 2. Foot Ankle Spec. 2009. PMID: 20400430
-
Apligraf in the treatment of neuropathic diabetic foot ulcers.Int J Low Extrem Wounds. 2009 Mar;8(1):11-8. doi: 10.1177/1534734609331597. Epub 2009 Feb 3. Int J Low Extrem Wounds. 2009. PMID: 19189997 Clinical Trial.
-
Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.Int Wound J. 2016 Apr;13(2):272-82. doi: 10.1111/iwj.12566. Epub 2015 Dec 23. Int Wound J. 2016. PMID: 26695998 Free PMC article. Clinical Trial.
-
Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.BioDrugs. 2002;16(6):439-55. doi: 10.2165/00063030-200216060-00005. BioDrugs. 2002. PMID: 12463767 Review.
-
Innovative therapies in wound healing.J Cutan Med Surg. 2003 May-Jun;7(3):217-24. doi: 10.1007/s10227-002-0106-5. J Cutan Med Surg. 2003. PMID: 12704530 Review.
Cited by
-
How to Select an Extracellular Matrix for Wound Repair: A Comprehensive Review.Eplasty. 2023 Aug 23;23:e51. eCollection 2023. Eplasty. 2023. PMID: 37664811 Free PMC article. Review.
-
An in situ forming gelatin-based hydrogel loaded with soluble amniotic membrane promotes full-thickness wound regeneration in rats.Iran J Basic Med Sci. 2024;27(8):1005-1014. doi: 10.22038/IJBMS.2024.74290.16140. Iran J Basic Med Sci. 2024. PMID: 38911243 Free PMC article.
-
3D Bioprinting of Functional Skin Substitutes: From Current Achievements to Future Goals.Pharmaceuticals (Basel). 2021 Apr 14;14(4):362. doi: 10.3390/ph14040362. Pharmaceuticals (Basel). 2021. PMID: 33919848 Free PMC article. Review.
-
Role of Oral Retinoids in Treatment of Acne Vulgaris With a Bioinformatics-Based Perspective of Personalized Medicine.Cureus. 2023 Apr 23;15(4):e38019. doi: 10.7759/cureus.38019. eCollection 2023 Apr. Cureus. 2023. PMID: 37228537 Free PMC article. Review.
-
An exploratory clinical study on the safety and efficacy of an autologous fibroblast-seeded artificial skin cultured with animal product-free medium in patients with diabetic foot ulcers.Int Wound J. 2014 Apr;11(2):183-9. doi: 10.1111/j.1742-481X.2012.01064.x. Epub 2012 Sep 7. Int Wound J. 2014. PMID: 22958543 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
